Cadaverine biosynthesis contributes to decreased Escherichia coli susceptibility to antibiotics

Res Microbiol. 2021 Nov-Dec;172(7-8):103881. doi: 10.1016/j.resmic.2021.103881. Epub 2021 Sep 20.

Abstract

Some bacterial stress responses are involved in survival under antibiotic treatment and contribute to less susceptible microbial forms selection. Here, we tested the role of cadaverine, one of the biogenic polyamines considered as universal adaptogens, in the processes. The expression of ldcC and cadA genes, encoding cadaverine-producing lysine decarboxylase, increased in Escherichia coli cells exposed to β-lactams and fluoroquinolones but not aminoglycosides. The transcriptional regulators RpoS and SoxS controlled the expression of ldcC and cadA, respectively, in response to antibiotics. Exogenous cadaverine had little effect on E. coli antibiotic susceptibility, whereas non-antibiotic-induced endogenous cadaverine contributed to its tolerance to β-lactams, fluoroquinolones, and aminoglycosides. Antibiotic-induced cadaverine synthesis promoted bacterial survival under fluoroquinolone exposure, as well as could contribute to low-resistant bacterial forms development. Selection under the fluoroquinolone levofloxacin exposure toward bacteria with an increased ability to synthesize cadaverine and negative correlation between LdcC activity and fluoroquinolone susceptibility in the selected forms were demonstrated. The same correlation in a special group of low-level resistant clinical E. coli isolates was revealed. So, cadaverine biosynthesis appeared to be a significant player in decreased E. coli antibiotic susceptibility development.

Keywords: Antibiotic tolerance; Fluoroquinolone; Lysine decarboxylase; Polyamines.

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Cadaverine* / biosynthesis
  • Cadaverine* / metabolism
  • Carboxy-Lyases / genetics
  • Carboxy-Lyases / metabolism
  • Drug Resistance, Bacterial*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology
  • Escherichia coli* / drug effects
  • Escherichia coli* / genetics
  • Escherichia coli* / metabolism
  • Fluoroquinolones / pharmacology
  • Gene Expression Regulation, Bacterial
  • Humans
  • Levofloxacin / pharmacology
  • Microbial Sensitivity Tests
  • Mutation
  • beta-Lactams / pharmacology

Substances

  • Anti-Bacterial Agents
  • beta-Lactams
  • Cadaverine
  • Carboxy-Lyases
  • Fluoroquinolones
  • Levofloxacin
  • lysine decarboxylase